Literature DB >> 21502545

Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer.

M Elizabeth Hammond, Daniel F Hayes, Antonio C Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21502545     DOI： 10.1200/JCO.2011.35.2245

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  49 in total

1.  Value of pre-treatment biomarkers in prediction of response to neoadjuvant endocrine therapy for hormone receptor-positive postmenopausal breast cancer.

Authors:  Min Ying; Yingjian He; Meng Qi; Bin Dong; Aiping Lu; Jinfeng Li; Yuntao Xie; Tianfeng Wang; Benyao Lin; Tao Ouyang
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

Review 2.  Identifying and targeting tumor-initiating cells in the treatment of breast cancer.

Authors:  Wei Wei; Michael T Lewis
Journal:  Endocr Relat Cancer       Date:  2015-04-15       Impact factor: 5.678

3.  Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial.

Authors:  K Kalinsky; J A Sparano; X Zhong; E Andreopoulou; B Taback; L Wiechmann; S M Feldman; P Ananthakrishnan; A Ahmad; S Cremers; A N Sireci; J R Cross; D K Marks; P Mundi; E Connolly; K D Crew; M A Maurer; H Hibshoosh; S Lee; D L Hershman
Journal:  Clin Transl Oncol       Date:  2018-05-07       Impact factor: 3.405

Review 4.  [Gene expression analysis in breast cancer. A new diagnostic tool in pathology].

Authors:  C Denkert
Journal:  Pathologe       Date:  2013-09       Impact factor: 1.011

5.  Trastuzumab-related cardiotoxicity among older patients with breast cancer.

Authors:  Mariana Chavez-MacGregor; Ning Zhang; Thomas A Buchholz; Yufeng Zhang; Jiangong Niu; Linda Elting; Benjamin D Smith; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

6.  Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression.

Authors:  Mark W Ball; Stephania M Bezerra; Alcides Chaux; Sheila F Faraj; Nilda Gonzalez-Roibon; Enrico Munari; Rajni Sharma; Trinity J Bivalacqua; George J Netto; Arthur L Burnett
Journal:  Urology       Date:  2016-02-18       Impact factor: 2.649

Review 7.  Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations.

Authors:  Nadia Harbeck; Rachel Wuerstlein
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

8.  cMET and phospho-cMET protein levels in breast cancers and survival outcomes.

Authors:  Kanwal P Raghav; Wenting Wang; Shuying Liu; Mariana Chavez-MacGregor; Xiaolong Meng; Gabriel N Hortobagyi; Gordon B Mills; Funda Meric-Bernstam; George R Blumenschein; Ana M Gonzalez-Angulo
Journal:  Clin Cancer Res       Date:  2012-02-28       Impact factor: 12.531

9.  Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.

Authors:  Kathleen Lambein; Mieke Van Bockstal; Lies Vandemaele; Rudy Van den Broecke; Veronique Cocquyt; Sofie Geenen; Hannelore Denys; Louis Libbrecht
Journal:  Virchows Arch       Date:  2017-05-31       Impact factor: 4.064

Review 10.  [Translational research and diagnostics for breast cancer].

Authors:  H H Kreipe
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.